BIOMAT Database Logo BIOMAT Database Logo

Report of the Working Party on Factor VIII Related Antigens. Addendum: the relationship between ristocetin co-factor activity (VIIIR:Cof) and Factor VIII related antigen (VIIIR:Ag). 1980

I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias

Related Publications

I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Report of the working party on factor VIII-related antigens.
April 1978, Thrombosis and haemostasis,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
December 1974, British journal of haematology,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
August 1983, Thrombosis and haemostasis,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Physical relationship between canine factor VIII coagulant activity and factor VIII-related antigen.
November 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
November 1984, American journal of clinical pathology,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
October 1974, Blut,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
October 2008, Journal of thrombosis and thrombolysis,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
November 1975, Thrombosis research,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
January 1975, Acta haematologica,
I M Nilsson, and I R Peake, and A L Bloom, and D Meyer, and J Veltkamp, and D Green
Factor VIII activity and factor VIII related antigen in newborns.
July 1978, European journal of pediatrics,
Copied contents to your clipboard!